AU4246793A - Topical ophthalmic compositions comprising a combination of calcium antagonists with known antiglaucoma agents - Google Patents

Topical ophthalmic compositions comprising a combination of calcium antagonists with known antiglaucoma agents

Info

Publication number
AU4246793A
AU4246793A AU42467/93A AU4246793A AU4246793A AU 4246793 A AU4246793 A AU 4246793A AU 42467/93 A AU42467/93 A AU 42467/93A AU 4246793 A AU4246793 A AU 4246793A AU 4246793 A AU4246793 A AU 4246793A
Authority
AU
Australia
Prior art keywords
composition
compound
intraocular pressure
calcium
calcium antagonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU42467/93A
Other languages
English (en)
Inventor
Louis DeSantis Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories Inc filed Critical Alcon Laboratories Inc
Publication of AU4246793A publication Critical patent/AU4246793A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU42467/93A 1992-05-13 1993-05-12 Topical ophthalmic compositions comprising a combination of calcium antagonists with known antiglaucoma agents Abandoned AU4246793A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88232892A 1992-05-13 1992-05-13
US882328 1992-05-13

Publications (1)

Publication Number Publication Date
AU4246793A true AU4246793A (en) 1993-12-13

Family

ID=25380354

Family Applications (1)

Application Number Title Priority Date Filing Date
AU42467/93A Abandoned AU4246793A (en) 1992-05-13 1993-05-12 Topical ophthalmic compositions comprising a combination of calcium antagonists with known antiglaucoma agents

Country Status (5)

Country Link
EP (1) EP0639986A1 (ja)
JP (1) JPH07508030A (ja)
AU (1) AU4246793A (ja)
CA (1) CA2131101A1 (ja)
WO (1) WO1993023082A1 (ja)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686879B1 (fr) * 1992-02-05 1994-03-18 Adir Cie Nouveaux composes de 1,4-dihydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant.
US5922773A (en) * 1992-12-04 1999-07-13 The Children's Medical Center Corp. Glaucoma treatment
US5756502A (en) * 1994-08-08 1998-05-26 Warner-Lambert Company Quinazolinone derivatives as cholyecystokinin (CCK) ligands
DE4430128A1 (de) * 1994-08-25 1996-02-29 Hoechst Ag Kombinationspräparat mit immunsuppressiven, kardiovaskulären und cerebralen Wirkungen
US5733938A (en) * 1994-09-09 1998-03-31 Allergan Combination of levobunolol and dipivefrin for topical ophthalmic use
US5780450A (en) * 1995-11-21 1998-07-14 Alcon Laboratories, Inc. Use of adenosine uptake inhibitors for treating retinal or optic nerve head damage
AU720326B2 (en) 1995-12-21 2000-05-25 Alcon Laboratories, Inc. Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia
US6225327B1 (en) 1996-04-18 2001-05-01 Alcon Laboratories, Inc. Compounds which inhibit human conjunctival mast cell degranulation for treating ocular allergic-type complications
WO1997040834A1 (fr) * 1996-04-26 1997-11-06 Fujisawa Pharmaceutical Co., Ltd. Agents ameliorant la circulation peripherique pour tissus ophthalmiques contenant des dihydropyridines
WO1997045118A1 (fr) * 1996-05-27 1997-12-04 Otsuka Pharmaceutical Co., Ltd. Agents ameliorant le flux sanguin ophtalmovasculaire et agents protecteurs des papilles optiques
CA2270119A1 (en) 1996-10-28 1998-05-07 Senju Pharmaceutical Co., Ltd. Drugs for ameliorating ocular circulatory disorders
IT1295423B1 (it) * 1997-10-10 1999-05-12 Medivis S R L Uso della flunarizina nella terapia topica del glaucoma
ES2224597T3 (es) 1998-01-29 2005-03-01 Akzo Nobel N.V. Agentes que mejoran la circulacion optica papilar.
WO2000057914A1 (fr) * 1999-03-25 2000-10-05 Santen Pharmaceutical Co., Ltd. Agents permettant d'abaisser la tension oculaire
US6482854B1 (en) 1999-03-25 2002-11-19 Massachusetts Eye And Ear Infirmary Glaucoma treatment
CA2369299A1 (en) * 1999-04-14 2000-10-19 Senju Pharmaceutical Co., Ltd. Inhibitor of visual function disturbance caused by optic nerve cell disorder due to factor other than ophthalmic circulatory disorder
WO2001041756A2 (en) * 1999-12-02 2001-06-14 University Of South Florida Method and composition for treatment of ischemic neuronal reperfusion injury
EP1265903B1 (en) * 2000-03-23 2004-05-12 Ortho-Mcneil Pharmaceutical, Inc. Thiepino[3,2-b]dihydropyridines and related compositions and methods
WO2001092267A2 (en) * 2000-05-30 2001-12-06 Ortho-Mcneil Pharmaceutical, Inc. Dihydropyridine compounds for the inhibition of calcium-influx
EP1426051B1 (en) * 2001-09-11 2008-07-16 Asahi Kasei Pharma Corporation Medicinal composition for prevention of or treatment for cerebrovascular disorder
TW200306839A (en) * 2002-02-06 2003-12-01 Novartis Ag Quinazolinone derivatives and their use as CB agonists
US20050176822A1 (en) * 2002-03-28 2005-08-11 Naoto Hanyu Phenylacetonitrile derivatives and hair tonics and external preparations for skin containing the derivatives
WO2004045644A1 (ja) 2002-11-18 2004-06-03 Santen Pharmaceutical Co., Ltd. Rhoキナーゼ阻害剤とβ遮断薬からなる緑内障治療剤
WO2004069275A1 (ja) * 2003-02-04 2004-08-19 Mitsubishi Pharma Corporation 眼科用剤
JP5576659B2 (ja) * 2006-12-05 2014-08-20 ザ ロイヤル インスティテューション フォー ジ アドバンスメント オブ ラーニング／ マギル ユニバーシティ Ｔｒｋレセプター調節因子の使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4911920A (en) * 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy
FR2577802B1 (fr) * 1985-02-26 1987-07-24 Synthelabo Compositions pharmaceutiques a base de betaxolol et de nifedipine
FR2585574B1 (fr) * 1985-07-31 1988-09-09 Corbiere Jerome Nouvelles compositions pharmaceutiques anti-glaucomateuses a base de 1,4-dihydropyridines et leur procede d'obtention
FR2593395A1 (fr) * 1986-01-28 1987-07-31 Corbiere Jerome Nouvelles compositions pharmaceutiques antiglaucomateuses a base de 3-acetoxy-5-(2-dimethylaminoethyl)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepine-4-one ou d'un de ses sels et leur procede d'obtention
US4981871A (en) * 1987-05-15 1991-01-01 Abelson Mark B Treatment of ocular hypertension with class I calcium channel blocking agents
JP2536806B2 (ja) * 1991-03-27 1996-09-25 アルコン ラボラトリーズ インコーポレイテッド ゲル化多糖類と微粉砕された薬剤担体とを組み合わせた局部眼科用組成物

Also Published As

Publication number Publication date
WO1993023082A1 (en) 1993-11-25
EP0639986A1 (en) 1995-03-01
CA2131101A1 (en) 1993-11-25
JPH07508030A (ja) 1995-09-07

Similar Documents

Publication Publication Date Title
AU4246793A (en) Topical ophthalmic compositions comprising a combination of calcium antagonists with known antiglaucoma agents
EP0868186B1 (en) Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia
EP0664707B1 (en) Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma
JP2732312B2 (ja) アルファ‐２作用薬及びベータ遮断薬の組合せを含む抗緑内障組成物
WO1995026711A1 (en) Ophthalmic composition with decreased viscosity
HU223070B1 (hu) Ionérzékeny, hidrofil polimert és szervetlen sót viszkozitáscsökkenést eredményező arányban tartalmazó szemészeti készítmény
AU704938B2 (en) Combination therapy for treating glaucoma
AU3082999A (en) Combination therapy for treating glaucoma
US6172054B1 (en) Combination therapy for lowering and controlling intraocular pressure
JP2004182723A (ja) Ｒｈｏキナーゼ阻害剤とβ遮断薬からなる緑内障治療剤
US4734438A (en) Norepinephrine potentiated compositions and method of use
EP0625903B1 (en) Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers
CA2240271C (en) Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia
AU2001217709B2 (en) Combination therapy for lowering and controlling intraocular pressure
WO1998014193A1 (en) The use of a substance p antagonist for the manufacture of a medicament for the treatment of ocular pain
AU2001217709A1 (en) Combination therapy for lowering and controlling intraocular pressure
EP0728480A1 (en) Use of ifenprodil for treatment of elevated intraocular pressure
EP0277814B1 (en) Anti-glaucoma use of trifluoromethanesulfonamide
AU2006200143B2 (en) Combination therapy for lowering and controlling intraocular pressure
AU2004214563A1 (en) Combination therapy for treating glaucoma